(NVS) Novartis - Performance 17.7% in 12m
NVS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
63.25%
#8 in Peer-Group
Rel. Strength
64.16%
#2658 in Stock-Universe
Total Return 12m
17.67%
#50 in Peer-Group
Total Return 5y
78.88%
#19 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 18.5 |
| P/E Forward | 14.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 121.01 USD |
| 52 Week Low | 93.41 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 86.23 |
| Buy/Sell Signal +-5 | 1.70 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NVS (17.7%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: NVS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NVS
| Total Return (including Dividends) | NVS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.69% | 2.04% | 4.55% |
| 3 Months | 8.55% | -7.24% | 10.78% |
| 12 Months | 17.67% | -5.41% | 14.71% |
| 5 Years | 78.88% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | NVS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 50.5% | 34.5% | 79.2% |
| 3 Months | 80.3% | -46.5% | 92.9% |
| 12 Months | 22.9% | -71.8% | 44.2% |
| 5 Years | 88.5% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th65.98 | 1.62% | -0.82% |
| 3 Month | %th62.89 | 17.03% | -2.01% |
| 12 Month | %th74.74 | 24.41% | 2.58% |
| 5 Years | %th90.72 | 24.58% | -15.83% |
FAQs
Does Novartis (NVS) outperform the market?
Yes,
over the last 12 months NVS made 17.67%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months NVS made 8.55%, while XLV made -7.24%.
Performance Comparison NVS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NVS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0% | -0.9% | 22.8% | 3% |
| US NASDAQ 100 | QQQ | -0.8% | -1.9% | 20.6% | 3% |
| German DAX 40 | DAX | 0.2% | 3.7% | 9.8% | -12% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.4% | -0.5% | 24.8% | 0% |
| Hongkong Hang Seng | HSI | 0.4% | -2.1% | 7% | -18% |
| India NIFTY 50 | INDA | 0.5% | 1.6% | 23.1% | 18% |
| Brasil Bovespa | EWZ | -1.3% | -4.1% | -1.7% | 4% |
NVS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.5% | -3.1% | 16.1% | -11% |
| Consumer Discretionary | XLY | 1.6% | 2.1% | 31.5% | -2% |
| Consumer Staples | XLP | 3.5% | 5.3% | 24.6% | 8% |
| Energy | XLE | 4.4% | 0.2% | 28.2% | 22% |
| Financial | XLF | -0.1% | 0.6% | 19.7% | -11% |
| Health Care | XLV | 1% | 1.7% | 30% | 23% |
| Industrial | XLI | 0.4% | -0.1% | 16.2% | -6% |
| Materials | XLB | 2% | 2.1% | 23.4% | 15% |
| Real Estate | XLRE | 4.5% | 3.7% | 25.4% | 5% |
| Technology | XLK | -1.3% | -5.2% | 19.6% | 6% |
| Utilities | XLU | 2.5% | 3.6% | 19.4% | -7% |
| Aerospace & Defense | XAR | -1.9% | -6.2% | 1.4% | -35% |
| Biotech | XBI | 2.2% | 1.6% | 36.7% | 29% |
| Homebuilder | XHB | 1.8% | -2.4% | 34.1% | 17% |
| Retail | XRT | 3.1% | 2.3% | 31.5% | 12% |
NVS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.3% | -1.43% | 32.1% | 28% |
| Natural Gas | UNG | 12.2% | 13.1% | 37.9% | 25% |
| Gold | GLD | 5% | 5.9% | 2.9% | -24% |
| Silver | SLV | 3.4% | -0.2% | 4.2% | -5% |
| Copper | CPER | -0.3% | -0.5% | 3.1% | 2% |
NVS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.3% | 0.1% | 26% | 16% |
| iShares High Yield Corp. Bond | HYG | 2.1% | 1.8% | 23.8% | 7% |